Your browser doesn't support javascript.
loading
Single-Institution Experience with Selective Internal Radiation Therapy (SIRT) for the Treatment of Primary and Secondary Hepatic Tumors.
Yammine, Kabalan; Kamar, Francois; Nasser, Jason; Tayar, Claude; Ghosn, Marwan; Chehade, Feras; Daher, Jihad; Nicolas, Gregory.
Afiliación
  • Yammine K; Radiology, Clemenceau Medical Center, Beirut, LBN.
  • Kamar F; Oncology, Clemenceau Medical Center, Beirut, LBN.
  • Nasser J; Medicine, Lebanese American University School of Medicine, Beirut, LBN.
  • Tayar C; Surgery, Clemenceau Medical Center, Beirut, LBN.
  • Ghosn M; Hematology and Oncology, Clemenceau Medical Center, Beirut, LBN.
  • Chehade F; Hematology and Oncology, Faculty of Medicine, Saint Joseph University, Beirut, LBN.
  • Daher J; Nuclear Medicine, Clemenceau Medical Center, Beirut, LBN.
  • Nicolas G; Radiology, Clemenceau Medical Center, Beirut, LBN.
Cureus ; 12(4): e7628, 2020 Apr 10.
Article en En | MEDLINE | ID: mdl-32399360
PURPOSE: We aim to provide results of the real-world experience of a single center in Lebanon on the use of radioembolization to treat liver-only or liver-dominant tumors.  Methods: This retrospective review included patients who were evaluated for radioembolization between January 2015 and June 2017 and who had a lung shunt fraction of 20% or less. Tumor responses were determined using the response evaluation criteria in solid tumors (RECIST). RESULTS: Of the 23 Arab patients with a median age of 64 years (range, 36-87 years), eight had hepatocellular carcinoma, four had cholangiocarcinoma, and 11 had liver-only or liver-dominant metastases from other primary cancers. Most (n=17) had multifocal lesions, and 13 had a history of branched (n=8) or main (n=5) portal vein thrombosis. When appropriate, the gastroduodenal artery and middle hepatic artery were embolized for consolidation of radiotherapy; 18 patients required arterial coil occlusion, two had their cystic artery occluded, and one developed cholecystitis, which was successfully treated with antibiotics and supportive care. Another patient developed a post-radioembolization complication-a peptic ulcer unrelated to arterial reflux of microspheres because both the gastroduodenal and right gastric arteries were occluded. The median time to progression was seven months (range, 3-36 months), and median overall survival from radioembolization was 12 months (range, 3-40 months). Tumor responses included five complete responses, 13 partial responses, one stable disease, and four cases of progressive disease.  Conclusion: Performing radioembolization in a non-referral, private center in Lebanon resulted in good patient outcomes with few complications.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos